Clinical Trial Update: Vedolizumab in Pediatric Ulcerative Colitis- Comparison With Infliximab [Phase 3]

View source ↗

Summary

Phase 3 pediatric ulcerative colitis trial comparing vedolizumab with infliximab is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Entyvio (vedolizumab)
• Remicade (infliximab)

Snippet

Sponsor: JAROSLAW KIERKUS | Conditions: Ulcerative Colitis | Phase 3 | Status: NOT_YET_RECRUITING